The page is the record's research on the issuer — no analyst, no rating, no view. # Veraxa Biotech AG - Post de-SPAC (NASDAQ: VRXAW) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Veraxa Biotech AG - Post de-SPAC, listed on NASDAQ under ticker VRXAW, with ISIN USH9130A1110. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-V8. Its security type is Non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is Switzerland. The issuer is listed and not halted. ## The disclosure read The record holds 50 filings in the twelve months to 2026-11-08, across 28 filing days. Of these, 13 are directors_dealings, 9 are prospectus, 19 are regulatory_filing and 9 are results. The median gap between filing days is 4 days. The latest filing is dated 2026-10-29 and is of type directors_dealings, and it sits 10 days before the record date. On NASDAQ the median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. In the sector 2834 Pharmaceutical Preparations the median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds three listing lines, dated 2026-06-09, 2026-06-10 and 2026-06-10. It holds no delisting and no name change. A domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. A segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. ## Coverage The field has not been read as a count of research houses on the issuer's investor-relations page; none was found on the pages read, and the count is zero. ## Open research No openly published research notes are on the record. None was found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002079109.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/VRXAW (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/VRXAW (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/VRXAW · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp